REGN Bathi saben saham sajrone rolas wulan pungkasan Regeneron Corp

Simbol lan logo merek Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN) drives innovation by leveraging academic culture and the expertise of leading geneticists. The annual net income per share demonstrates the fundamental strength of the business, where the value of 45.48 determines the magnitude of the metric. An impeccable medical reputation built on breakthrough drugs is coupled with high liquidity, which effectively mitigates patent risks.

REGN (Regeneron Pharmaceuticals) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 18.11.2026

Rincian analitis lan laporan data perusahaan Regeneron Corp (REGN)

- rega saham lan target rega konsensus:
- data kapitalisasi pasar:
Pambiji fundamental:Regeneron - REGN
Produk seri Regeneron Inc.

This indicator reflects the actual portion of net profit attributable to a single common share per year, allowing for an assessment of capital generation efficiency regardless of the total number of shares issued. By analyzing the rolling earnings per share trend, an investor can determine the monetization pace of the Regeneron Pharmaceuticals (REGN) strategy to protect key drugs and expand into oncology segments through investments in genetics.